Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7329681
Inhibitors of IMPDH enzyme
granted -
US 7329652
Diaminotriazole compounds useful as protein kinase inhibitors
granted -
US 7326713
Substituted tricyclic compound as protein kinase inhibitors
granted -
US 7326712
Substituted tricyclic compounds as protein kinase inhibitors
granted -
US 7323171
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
granted -
US 7320991
Analogs of thalidomide as potential angiogenesis inhibitors
granted -
US 7321063
Sulfonamide inhibitors of aspartyl protease
granted -
US 7314885
Pyrrole compounds useful as kinase inhibitors
granted -
US 7312226
Substituted tricyclic compounds as protein kinase inhibitors
granted -
US 7312227
Compositions useful as inhibitors of JAK and other protein kinases
granted -
US 7306799
Use of VEGF inhibitors for treatment of eye disorders
granted -
US 7304071
Protein kinase inhibitors and uses thereof
granted -
US 7304061
Heterocyclic inhibitors of ERK2 and uses thereof
granted -
US 7303747
Use of VEGF inhibitors for treatment of eye disorders
granted -
US 7288624
Inhibitors of interleukin-1β converting enzyme
granted -
US 7285556
Thienopyrimidine-based inhibitors of the src family
granted -
US 7279469
Diaminotriazoles useful as inhibitors of protein kinases
granted -
US 7279476
Pyrazole-derived kinase inhibitors and uses thereof
granted -
US 7276502
Thiazoles useful as inhibitors of protein kinases
granted -
US 7276348
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
granted -
US 7273851
Tri-peptide hepatitis C serine protease inhibitors
granted -
US 7273885
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted -
US 7271179
Inhibitors of JAK protein kinase
granted -
US 7271181
Inhibitors of p38
granted